Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Osteoarthritis of the Knee: early-phase trial registry

3 of 17 indexed Osteoarthritis of the Knee trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,004 of 28,707 conditions by registered trial count.

17 US clinical trials · 3 currently recruiting · #1,004 of 28,707 conditions by registered trial count

Osteoarthritis of the Knee: 17 US clinical trials tracked, 3 recruiting.

Osteoarthritis of the Knee is the subject of 17 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Pacira Pharmaceuticals, running 4 of these trials.

Enrollment posture brief

Registry condition osteoarthritis-of-the-knee

OPEN 3 | RECR 18% | LATE 4 | EARLY 7 | RANK #1004 | SPON 4

Nearest open-share peer: Advanced Malignant Neoplasm (18% recruiting · 17 trials)

Acute Myeloid Leukemia, in R70.6%Abdominal Aortic Aneurysm52.9%Acute Lymphoblastic Leukemia23.5%Osteoarthritis of the Kn (th…18%Actinic Keratosis11.8%
Open-enrollment share among volume-matched conditions near Osteoarthritis of the Knee

Osteoarthritis of the Knee lists 3 open slots (18% of 17 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Osteoarthritis of the Knee on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Osteoarthritis of the Knee is recruiting below its size-band peers.

    3 of 17 indexed trials (17.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Osteoarthritis of the Knee research.

    Pacira Pharmaceuticals accounts for 4 of 17 trials (23.5%). 13 distinct sponsors appear on at least one study for this condition label.

  3. Typical Osteoarthritis of the Knee enrolment sits around 177 participants.

    Median target enrolment is 177 among the 17 trials that report a genuine target (sentinel values excluded). 5 of those (29.4%) plan for fewer than 100 participants.

  4. Osteoarthritis of the Knee research is mostly interventional.

    17 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 26Phase 34

Open and recent trials

17 total, page 1 of 1

RECRUITING Phase 2 200 participants

Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee

Steven E Harte, PhD

NCT04992624

RECRUITING NA 100 participants

Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection

Rush University Medical Center

NCT05985785

RECRUITING NA 82 participants

Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis

Steadman Philippon Research Institute

NCT07397806

ACTIVE NOT RECRUITING Phase 3 221 participants

A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee Marching On for Veterans With Osteoarthritis of the Knee

VA Office of Research and Development

NCT05035810

COMPLETED Phase 3 504 participants

Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain

Taiwan Liposome Company

NCT04123561

COMPLETED Phase 3 486 participants

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Pacira Pharmaceuticals

NCT02357459

COMPLETED Phase 2 389 participants

A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee

Teva Branded Pharmaceutical Products R&D

NCT02068599

COMPLETED Phase 2 310 participants

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

Pacira Pharmaceuticals

NCT02116972

COMPLETED Phase 2 289 participants

A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis

Noven Pharmaceuticals

NCT03277066

COMPLETED Phase 3 208 participants

Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee

Pacira Pharmaceuticals

NCT03046446

COMPLETED NA 177 participants

Cooled Radiofrequency vs. Hyaluronic Acid to Manage Knee Pain

Avanos Medical

NCT03381248

COMPLETED NA 153 participants

Coolief Cooled Radiofrequency vs. Conventional Radiofrequency to Manage OA Knee Pain

Avanos Medical

NCT04145011

COMPLETED NA 151 participants

Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain

Halyard Health

NCT02343003

COMPLETED NA 48 participants

Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis

University of Rochester

NCT01683799

COMPLETED Phase 2 33 participants

Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes

Pacira Pharmaceuticals

NCT02762370

COMPLETED Phase 1 29 participants

Effects of Aquamin F on NSAID Dose Reduction in Osteoarthritis of the Knee

Marigot

NCT00755482

COMPLETED Phase 2 21 participants

Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee

Stanford University

NCT01645176

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 6
Phase 3 4

Named interventions

Most-linked intervention names on Osteoarthritis of the Knee records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
4 trials
Cooled Radiofrequency Device
3 trials
FX006 32 mg Drug
3 trials
Hydroxychloroquine/Atorvastatin Drug
1 trials
Placebo (maltodextran) Drug
1 trials
Aquamin F Drug
1 trials
Standard Radiofrequency Device
1 trials
Crossover from Hyaluronic Acid Injection to Cooled Radiofrequency Other
1 trials

US sites by state

Facility locations filed on Osteoarthritis of the Knee trials. A trial with sites in several states counts in each.

California 8 trials
Pennsylvania 7 trials
South Carolina 5 trials
Florida 5 trials
Arizona 5 trials
Virginia 3 trials
Tennessee 3 trials
New York 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Osteoarthritis of the Knee page

17 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Osteoarthritis of the Knee trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Pacira Pharmaceuticals sponsors the most Osteoarthritis of the Knee trials on record, review their full trial history before evaluating a specific study. See Pacira Pharmaceuticals's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Osteoarthritis of the Knee condition card totals 17 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.